Nektar Therapeutics | NKTR - Actif À Court Terme





Actif À Court Terme Changement Date
Agios Pharmaceuticals USD 752.1M 34.43M 2026-09
ALKERMES USD 1.58B 57.83M 2026-09
Alterity Therapeutics Limited AUD 37.91M 15.92M 2025-12
Amgen USD 34.36B 598M 2026-09
Baxter International USD 6.83B 163M 2026-09
BioCryst Pharmaceuticals USD 531.15M 46.47M 2026-09
Biogen USD 7.58B 278.7M 2026-09
Bristol-Myers Squibb USD 29.77B 1.19B 2026-09
Cara Therapeutics USD 25.33M 6.21M 2026-03
Cipla INR 250.61B 9.14B 2026-09
Dr.Reddys Laboratories INR 297.32B 2.01B 2026-09
Eisai JPY 883.01B 121.38B 2026-06
Eli Lilly USD 65.26B 591M 2026-09
Exelixis USD 1.32B 70.8M 2026-09
Gilead Sciences USD 16.55B 4.02B 2026-09
GlaxoSmithKline GBP 17.9B 336M 2026-09
Grifols EUR 5.96B 316.31M 2025-12
Halozyme Therapeutics USD 1.85B 913.71M 2026-09
Incyte USD 5.52B 505.2M 2026-09
Ionis Pharmaceuticals USD 2.49B 446.73M 2026-06
Ironwood Pharmaceuticals USD 225.99M 26.79M 2026-09
Karyopharm Therapeutics USD 126.33M 23.19M 2026-03
MacroGenics USD 321.69M 139.16M 2026-06
Merck USD 38.94B 2.26B 2026-09
Nektar Therapeutics USD 589.04M 322.77M 2026-03
Neurocrine Biosciences USD 2.01B 370.7M 2026-09
Novartis USD 28.75B 1.4B 2026-09
Pfizer USD 45.01B 3.65B 2026-09
Roche Holding CHF 35.44B 3.29B 2026-06
Sarepta Therapeutics USD 2.27B 49.06M 2026-09
Takeda JPY 3T 153.11B 2026-09
Teva Pharmaceutical Industries USD 14.6B 842M 2026-09
Xencor USD 498.66M 24.55M 2026-09